liver cirrhosis
Conditions
Interventions
None listed
Sponsors
Nagoya University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Clinically diagnosed with liver cirrhosis Has a platelet count of either 20,000-90,000/microL or 90,000-150,000/microL 18 years of age or older
Exclusion criteria
Exclusion criteria: Patients requested to be excluded from the main study Patients with congenital platelet function disorders such as Glanzmann's thrombasthenia or Bernard-Soulier syndrome or von Willebrand disease Patients currently taking antiplatelet or anticoagulant medications Patients with severe anemia or hypoalbuminemia Patients with embolic diseases such as myocardial infarction, cerebral infarction, or pulmonary embolism Patients presenting with DIC due to severe infections, active bleeding, cancer, hematologic malignancies, or poor general condition Any other patients deemed unsuitable for safe participation in this study by the attending physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Examination of the correlation coefficient between bleeding time and hemostatic capacity measured by the HD assay in cirrhotic patients with platelet counts below 90,000/microL | — |
Countries
Japan
Contacts
Public ContactImai Norihiro
Nagoya University Graduate School of Medicine Gastroenterology
Outcome results
None listed